Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The classification of Fertility Enhancing Treatment includes Fertility Drugs for Women, Fertility Drugs for Men and OTC Conception Gels/Lubricants, and the proportion of Fertility Drugs for Women in 2017 is about 88%.
North America and Europe are the two largest consumption place, with a similar consumption market share nearly 33% in 2017. Following North America and Europe, China is the third consumption place with the consumption market share of 9.4%.
According to this study, over the next five years the Fertility Enhancing Treatment market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 5600 million by 2024, from US$ 4380 million in 2019. In particular, this report presents the global revenue market share of key companies in Fertility Enhancing Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Fertility Enhancing Treatment market by product type, application, key companies and key regions.
This study considers the Fertility Enhancing Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Fertility Drugs for Women
Fertility Drugs for Men
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Drug Stores
Online
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church?Dwight
SASMAR
BioFilm,Inc
FAIRHAVEN HEALTH
The YES YES Company
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Fertility Enhancing Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fertility Enhancing Treatment market by identifying its various subsegments.
Focuses on the key global Fertility Enhancing Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fertility Enhancing Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Fertility Enhancing Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
